In episode 453, James and Mike invite Jessica Kirkwood to go over all the evidence for transitioning infants to solid foods using a baby-led weaning approach versus traditional spoon feeding. Overall, it really didn’t make much difference which approach was used. But listen to hear us take a bite out of all the nuances and context.

Show notes 

Tools for Practice

 “Does baby know best?”: Benefits and harms of baby-led weaning for transitioning to solid foods

In episode 452, James and Mike go over 2 recent publications which encapsulate all the important evidence around type 2 diabetes. We talk about the misdirection that occurs with T2DM evidence versus what we do in practice. We now have all the evidence and we know what these medications do or don’t do to important clinical endpoints. Could we please use this information when we treat T2DM.

Show notes 

Penn & Teller Give a Lesson in Misdirection Using a Vanishing Chicken

1) Comparative Effectiveness of Glucose-Lowering Drugs for

Type 2 Diabetes – A Systematic Review and Network Meta-analysis

Ann Intern Med. 2020 Jun 30.  doi: 10.7326/M20-0864

2) Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map

Lancet Diabetes Endocrinol. 2020 Mar;8(3):192-205

In episode 451, Mike and James invite Adrienne to talk about how we put all the osteoarthritis evidence into a simplified decision guide. We talk about how we produce these decision guides and also give tips and suggestions around how to use the evidence with patients.

Show notes 

PEER simplified decision aid: osteoarthritis treatment options in primary care. 

Can Fam Physician 2020;66:191-3

In episode 450 Mike and James continue, with Danielle and Joey, going over our osteoarthritis systematic review. We talk in detail about all the evidence around oral NSAIDs, glucosamine, topical NSAIDs, chondroitin, viscosupplementation, oral opioids, acetaminophen. And now you know all the numbers.

Show notes 

PEER Umbrella Systematic Review of Systematic Reviews: Management of Osteoarthritis in Primary Care

Can Fam Phy 2020 Mar;66(3):e89-e98

In episode 449, Mike and James invite Danielle Perry and Joey Ton to go over our osteoarthritis systematic review. We talk about all the evidence around exercise, steroid injections, SNRIs, oral NSAIDs, glucosamine, topical NSAIDs, chondroitin, viscosupplementation, oral opioids, acetaminophen. In fact, the magnitude of benefit is exactly in this order – exercise highest, acetaminophen lowest.

Show notes 

PEER Umbrella Systematic Review of Systematic Reviews: Management of Osteoarthritis in Primary Care

Can Fam Phy 2020 Mar;66(3):e89-e98.

In episode 448, Mike and James go over all the evidence around masks for preventing viral respiratory infections in healthcare workers. We find that surgical masks and N95 masks provide similar protection against viral infections. Unfortunately we have no evidence for COVID-19.

Show notes 

Tools for Practice

Unmasking the evidence around masks for healthcare workers

COVID Webinar

May 7

The COVID-19 Pivot: Rapid evidence reviews with the PEER team

In episode 447, Mike and James invite Tina and Mike to talk about a really important topic – is there asymptomatic transmission of COVID-19? The simple answer is yes. Have a listen and hear about all the data and the numbers.

Show notes 

Tools for Practice

Stealth style transmission? Covert data on COVID-19

In episode 446, Mike and James invite Mike and Tina to talk about all things COVID. In this podcast we look at what are the presenting symptoms, the clinical course and the risk factors for mortality.  

Show notes 

Tools for Practice

A rushed introduction to an uninvited guest

In episode 445, Mike and James wade into the evidence-free zone (pretty much) around assessing dyspnea over a telephone/video conference. We talk about the Roth score, respiratory rate, fever, and patient self-rating of dyspnea. Have a listen and see what we found.

Show notes

The BMJ

Covid-19: a remote assessment in primary care

In episode 444, James and Mike wade into the evidence quagmire around hydroxychloroquine and COVID-19.  The bottom line is the evidence will likely be different around the time you listen to the podcast. So listen quickly.

Show notes

1)Tools for Practice

Hydroxychloroquine with or without azithromycin for COVID-19

2) Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial